A Case Series on Patients on Tofacitinib in Combination With a Biologic

被引：18

作者：

Barroso, Nashla S. ^{[1
]}

Miller, Elizabeth Z. ^{[1
]}

Furst, Daniel E. ^{[1
,2
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Rheumatol, Los Angeles, CA 90095 USA

[2] Pacific Arthrit, Los Angeles, CA USA

来源：

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2018年 / 24卷 / 06期

关键词：

RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; DOUBLE-BLIND; CLASSIFICATION; INHIBITION; CRITERIA; THERAPY; TRIAL;

D O I：

10.1097/RHU.0000000000000663

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：349 / 351

页数：3

共 14 条

[1]

[Anonymous], 2016, What is a serious adverse event?

[2] THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].

ARNETT, FC ;

EDWORTHY, SM ;

BLOCH, DA ;

MCSHANE, DJ ;

FRIES, JF ;

COOPER, NS ;

HEALEY, LA ;

KAPLAN, SR ;

LIANG, MH ;

LUTHRA, HS ;

MEDSGER, TA ;

MITCHELL, DM ;

NEUSTADT, DH ;

PINALS, RS ;

SCHALLER, JG ;

SHARP, JT ;

WILDER, RL ;

HUNDER, GG .

ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324

[3] Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist [J].

Charles-Schoeman, Christina ;

Gonzalez-Gay, Miguel A. ;

Kaplan, Irina ;

Boy, Mary ;

Geier, Jamie ;

Luo, Zhen ;

Zuckerman, Andrea ;

Riese, Richard .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2016, 46 (01) :71-80

[4] Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks [J].

Cohen, Stanley B. ;

Emery, Paul ;

Greenwald, Maria W. ;

Dougados, Maxime ;

Furie, Richard A. ;

Genovese, Mark C. ;

Keystone, Edward C. ;

Loveless, James E. ;

Burmester, Gerd-Ruediger ;

Cravets, Matthew W. ;

Hessey, Eva W. ;

Shaw, Timothy ;

Totoritis, Mark C. .

ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2793-2806

[5] Combination Biologic Treatment of Refractory Psoriasis and Psoriatic Arthritis [J].

Cuchacovich, Raquel ;

Garcia-Valladares, Ignacio ;

Espinoza, Luis R. .

JOURNAL OF RHEUMATOLOGY, 2012, 39 (01) :187-193

[6] Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review [J].

Downey, Colum .

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (06) :536-550

[7] Abatacept for rheumatoid arthritis refractory to tumor necrosis factor α inhibition [J].

Genovese, MC ;

Becker, J ;

Schiff, M ;

Luggen, M ;

Sherrer, Y ;

Kremer, J ;

Birbara, C ;

Box, J ;

Natarajan, K ;

Nuamah, I ;

Li, T ;

Aranda, R ;

Hagerty, DT ;

Dougados, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (11) :1114-1123

[8] Effect of Combination Therapy on Joint Destruction in Rheumatoid Arthritis: A Network Meta-Analysis of Randomized Controlled Trials [J].

Graudal, Niels ;

Hubeck-Graudal, Thorbjorn ;

Tarp, Simon ;

Christensen, Robin ;

Jurgens, Gesche .

PLOS ONE, 2014, 9 (09)

[9] Tofacitinib versus Methotrexate in Rheumatoid Arthritis [J].

Lee, Eun Bong ;

Fleischmann, Roy ;

Hall, Stephen ;

Wilkinson, Bethanie ;

Bradley, John D. ;

Gruben, David ;

Koncz, Tamas ;

Krishnaswami, Sriram ;

Wallenstein, Gene V. ;

Zang, Chuanbo ;

Zwillich, Samuel H. ;

van Vollenhoven, Ronald F. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (25) :2377-2386

[10] Rituximab for the treatment of rheumatoid arthritis: an update [J].

Mok, Chi Chiu .

DRUG DESIGN DEVELOPMENT AND THERAPY, 2014, 8 :87-100

← 1 2 →